Affordability Check
How to afford Vabrinty
Generic name: Leuprolide acetate
Pick how you're covered. We'll show you the cheapest legitimate way to get Vabrinty — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.
Pick an option above to see your specific path.
Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.
About Vabrinty and its cost
What is this medication? Simbrinza is a prescription eye drop used to reduce high pressure inside the eyes of patients suffering from open-angle glaucoma or ocular hypertension. It contains two active medications, brinzolamide and brimonidine tartrate, which function in tandem to lower intraocular pressure. Brinzolamide works by slowing the production of fluid within the eye, while brimonidine tartrate helps to both decrease fluid production and improve the flow of fluid out of the eye. Lowering this pressure is essential for preventing damage to the optic nerve and avoiding potential blindness. This medication is generally recommended for patients who require multiple treatments to manage their eye pressure effectively. Because high eye pressure often presents no symptoms until vision loss occurs, it is vital to use Simbrinza exactly as prescribed by a healthcare provider. While the medication does not cure glaucoma, its regular use is a key component in a long-term strategy to preserve vision and manage the underlying ocular conditions that lead to increased pressure.
Vabrinty is made by Alcon Laboratories, Inc.. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.
Common questions
What's the cheapest way to afford Vabrinty?
It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.
Can I use a copay card with Medicare for Vabrinty?
No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But Alcon Laboratories, Inc. has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.
Does my Medicare Part D plan cover Vabrinty?
Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.
How long does a Patient Assistance Program take?
Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.
What if I have a high-deductible plan?
For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.
Are there charity grants for Prostate Cancer?
Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.
More about Vabrinty
Full Vabrinty drug page
FDA label, prior authorization rules, full indications list
More options for Prostate Cancer
Drugs, grants, and assistance for this condition
Guide to Patient Assistance Programs
How PAPs work, who qualifies, typical wait times
If your insurance denied coverage
5-level appeal playbook — Medicare has a 60% win rate at Level 3